Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Continuum Health Ventures (CHV) is an early-stage venture capital fund based globally, with a focus on Healthtech, Techbio, and Healthspan Extension startups. Founded to support innovative healthcare solutions, CHV targets pre-seed to seed-plus stages and has a diverse portfolio across the United States, Canada, the Middle East, India, Japan, South Korea, and Singapore.
CHV invests in startups that digitize healthcare and improve health outcomes, particularly those emphasizing personalized interventions and the potential to reverse aging-related diseases. Their investment range includes pre-seed, seed, and seed-plus stages, with check sizes tailored to early-stage funding needs.
Notable portfolio companies include Ampa Health, which democratizes access to neurotechnology tools for brain disorders; Sanctuary AI, focused on creating highly dexterous mobile robots with General Machine Intelligence; Biotia, utilizing AI for rapid precision infectious disease discovery; Immunis, developing biologics for age-related conditions; and Cardiatech Bio, discovering novel cardiovascular therapeutics through multiomics.
Submit through their form at https://www.continuumhealth.vc/contact.
CHV often leads investment rounds, particularly in the pre-seed and seed stages, to provide startups with the necessary capital and support to scale.
CHV is open to follow-on investments, especially for companies that demonstrate significant progress and alignment with their healthtech and longevity focus.
The specific size of CHV's current fund is not publicly disclosed, but they actively engage in funding early-stage healthtech startups.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.